期刊
EUROPEAN JOURNAL OF INTERNAL MEDICINE
卷 48, 期 -, 页码 18-24出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejim.2017.10.005
关键词
Obesity; Metabolic disease; Gut microbiota
资金
- European Metacardis project [HEALTH-F4_2012_305312]
- Heart and Artery Association (Fondacoeur)
- clinical research contracts (AP/HP Microbaria)
- National Research Agency (ANR)
The composition and function of gut microbiota play a role in obesity and metabolic disease, yet the mechanisms have not been fully described. As new discoveries and advances in the field have occurred, the relevance of gut microbiota in clinical care has become more substantial. There is promising potential for manipulation of the gut microbiota as treatment of obesity and associated health complications, both as a standalone therapy and as part of interventions such as weight loss. In this review we have compiled knowledge and concepts that are important in the consideration of gut microbiota for clinical care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据